Brief: Index Pharmaceuticals Gets Cobitolimod Patent in Europe

Flerie AB

02/08/2023 06:46

Aug 2 (Reuters) - InDex Pharmaceuticals Holding AB
 INDEX.ST :
    * HAS BEEN GRANTED A NEW PATENT IN EUROPE FOR THE COMMERCIAL
FORMULATION OF COBITOLIMOD
    * PATENT WILL PROVIDE AN EXCLUSIVITY PERIOD UNTIL SEPT 2042,
WITH
POSSIBILITY OF UP TO 5 YEARS EXTENSION

Source text for Eikon:  ID:nWkr2sZrSN 
Further company coverage:  INDEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))